Body Central Corp. (BODY) Tops Q1 EPS by 4c, SSS Rose 30.3%, Posts Strong Q2 Guidance
Tweet
Share
E-mailGet Alerts BODY Hot Sheet
Join SI Premium – FREE
Body Central Corp. (NASDAQ: BODY) reported Q1 EPS of $0.34, $0.04 better than the analyst estimate of $0.30. Revenue for the quarter came in at $74 million versus the consensus estimate of $72.11 million.
Store sales rose 30.3% to $63.3 million driven by a comparable-store sales increase of 16.1% and net store unit growth.
Body Central Corp. sees Q2 2011 EPS of $0.28-$0.30, versus the consensus of $0.30. Body Central Corp. sees Q2 2011 revenue of $71-$73 million, versus the consensus of $75.21 million.
Store sales rose 30.3% to $63.3 million driven by a comparable-store sales increase of 16.1% and net store unit growth.
Body Central Corp. sees Q2 2011 EPS of $0.28-$0.30, versus the consensus of $0.30. Body Central Corp. sees Q2 2011 revenue of $71-$73 million, versus the consensus of $75.21 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
- Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
